**What was known?**

*Malassezia* cause superficial mycoses and rarely systemic infections. They do not express drug resistance.

Introduction {#sec1-1}
============

*Malassezia* (earlier known as Pityrosporum) species form the cutaneous commensal flora, which are associated with varied clinical manifestations ranging from benign skin conditions, such as tinea versicolor, to fungemia in the immunocompromised host.\[[@ref1]\] There are at present 14 described species, namely *M. furfur*, *M. pachydermatis*, *M. sympodialis*, *M. globosa*, *M. obtusa*, *M. restricta*, *M. slooffiae*, *M. equina*, *M. dermatis*, *M. japonica*, *M. nana*, *M. capre*, *M. yamatoensis, and* most recently *M. cuniculi*.\[[@ref2]\] Owing to their lipophilic nature, they colonize the seborrheic parts of the skin and they sustain themselves by using the fatty acids present in normal sebum. They cause skin disease in certain conditions such as overgrowth, descent into hair follicles, or inflammation. Though, by definition superficial mycosis do not extend beyond the cornified epithelium, these organism are seen in the ostium, central and deep segments of the hair follicle in *Malassezia* (Pityrosporum) folliculitis. *Malassezia* infections can manifest as superficial localized or can cause systemic infections in immunocompromised hosts.\[[@ref3]\]

Skin distribution {#sec1-2}
=================

The density of skin colonization with *Malassezia* depends on age, body site, and comorbid skin conditions, as well as the geographic area. Being lipophilic, *Malassezia* are found in the highest density in sebaceous areas such as the scalp, face, and upper trunk. It is seen in higher densities in young adults, who tend to have relatively oily skin.\[[@ref3]\]

Factors responsible for overgrowth of *Malassezia* {#sec1-3}
==================================================

Geographical: Geographical variations have been observed in the densities of different *Malassezia* species on the skin. It is seen more commonly in the warm and humid tropical and subtropical climates which is more suited for its growth. Reports show the growth of *M. globosa* tends to increase in summer when temperatures are high and due to sweat.\[[@ref4]\]

Age: The age group that commonly gets affected with pityriasis versicolor (PV) is that from 20 to 40 years. However, in India, it has been commonly observed the age group between 10 and 30 years PV is uncommon in children and is rarely found in the elderly.\[[@ref5][@ref6][@ref7][@ref8]\]

Hormonal factors: Patients who are on corticosteroid therapy, malnutrition and increased plasma cortisol levels have shown to mediate PV.\[[@ref9]\]

Pathogenesis: Human sebum is the lipid source these yeasts thrive on because it is a complex mixture of lipids. It contains triglycerides, fatty acids, wax esters, sterol esters, cholesterol, cholesterol esters, and squalene. Sebum is utilized by breaking down triglycerides and esters, into diglycerides, monoglycerides, and free fatty acids. Thus, alteration in sebum secretion and its break down helps in the development of dandruff. *Malassezia* infections are also associated with hyperhydrosis.\[[@ref10][@ref11][@ref12][@ref13][@ref14]\]

Clinical scenario {#sec1-4}
=================

*Malassezia* yeasts cause chronic recurrent dermatoses like PV, seborrhoeic dermatitis (SD), and *Malassezia* folliculitis. Recently, it has been proven that they play a role in the pathogenesis of atopic dermatitis and psoriasis, especially in cases involving the scalp. Furthermore, confluent and reticulate papillomatosis and reports of onychomycosis have also mentioned *Malassezia* as causative agents. These yeasts are also associated in catheter-related blood stream infections (CRBSI) among newborns receiving total parenteral nutrition (TPN), and in immunocompromised elderly receiving parenteral lipid supplements. Fungemia and sepsis due to *Malassezia furfur* and *M. pachydermatis* may occur particularly in such patients.\[[@ref1][@ref15]\]

 {#sec2-1}

### Pityriasis versicolor {#sec3-1}

It is the prototype *Malassezia* infection. PV, also known as tinea versicolor, is a commonly encountered superficial mycosis, which is a chronically recurring infection of the stratum corneum. It is characterized by fine white scaly, hypo or hyperpigmented macules that are irregular and most often occurring on the oily parts of the body, trunk and extremities. Some patients may experience pruritus, but most are asymptomatic.\[[@ref1]\] Pityron in Greek means scale.\[[@ref3][@ref16]\]

Neumann *et al.*\[[@ref17]\] described that it was the mycelial form of *Malassezia* which was associated with PV lesions way back in 1871. *Malassezia* was successfully cultured by Neumann *et al.*, and Gordon *et al.*,\[[@ref18]\] It was also established that the yeast form was seen in lesions of PV and in normal skin. It was found that the filament production had to occur on a "massive scale" to produce clinical lesions of PV and they had to be the variety that produced serovar A antigen.\[[@ref1]\]

Differential diagnosis

The look alike lesions are pityriasis alba, pityriasis rosea, vitiligo, hypopigmented mycosis fungoides, erythrasma and seborrheic dermatitis.

Diagnosis

PV is diagnosed clinically, with seldom a need for biopsy or culture. Under a Wood\'s lamp, PV may fluoresce yellow. 10% KOH wet mount shows the nonseptate, short, curved, angulated or straight hypha, and bunches of spores showing "spaghetti and meatball" appearance.

Histopathological examination

Though rarely biopsied, tinea versicolor shows spores (yeast form) and short hyphae (mycelium) in the stratum corneum that stain positive with fungal stains like diazonium blue, periodic acid--Schiff stain or methenamine silver stains. Moderate hyperkeratosis and rarely acanthosis have been observed.\[[@ref3]\]

Species of *Malassezia* isolated from pv

While speciating isolates among PV specimens,\[[@ref19][@ref20][@ref21][@ref22]\] *M. globosa* was the most common species, at the frequencies of 58.2%, 55%, 55% and 53.3%, respectively. A study from north-central India showed 54% of *M. globosa*, and 30% *M. furfur*. A few studies found *M. furfur* predominantly. Makimura *et al.* isolated *M. furfur* and *M. sympodialis* in temperate climate; however, in tropical countries, they isolated *M. globosa*.\[[@ref23][@ref24][@ref25]\]

*M. globosa*\'s pathogenicity can be explained by its high esterase and lipolytic activity. Unlike other mycosis, here, center of the lesions yielded more viable materials for culture.\[[@ref26]\]

### Seborrhoeic dermatitis {#sec3-2}

SD is the second most common infection associated with *Malassezia*, which was initially described by Unna PG in 1887. SD is a superficial eczematous dermatitis, either sub-acute or chronic, characterized by erythematous plaques with dry or oily scale. It occurs in sebaceous areas like the scalp, face, ears, chest, and axillary areas. Mild corticosteroids have proven effective in treatment.

However, the recurring nature of this disease often within just a few days makes it challenging. Antifungal therapy should be the primary treatment of this disease as the use of corticosteroids don't help in reduction of the number of *Malassezia*.\[[@ref3][@ref27]\]

The prevalence of seborrheic dermatitis peaks during the period of increased sebaceous gland activity.\[[@ref16]\]

First 3 months of life (infantile seborrheic dermatitis)During pubertyWhen sebum excretion is reduced after the age of 50 year.\[[@ref16]\]

3--5% of the general population suffers from this and is seen more in men than in women. In immunocompetent individuals, SD generally begins during high sebum secretion, i.e. during puberty and becomes chronic and relapses frequently. Stress is known to exacerbate SD. In patients with AIDS, it may be 30% to 80% and is more refractory to topical antifungal therapy than in immunocompetent individuals.\[[@ref28]\]

In HIV patients, onset of SD is a surrogate marker for CD4 T-lymphocyte cell suppression. *M. restricta* and *M. globosa* are seen predominantly in the scalp, in both health and disease.\[[@ref29]\]

Pathogenesis

The immunopathogenesis of SD is complex and multifactorial.

There are culture-based evidences for higher densities of colonies in lesional skin in comparison to normal controls. However, sample retrieving techniques have to be standardized to prove it. Quorum sensing has been an area of great interest in recent times and *Malassezia* are known to work as "quorums."

*Malassezia* are also antigenically complex, exhibiting both protein and carbohydrate antigens, which are also associated with the stages in their life cycle; the former in the early stages of growth, and associated with the maturing cell wall and the establishing cytoplasmic organelle, the latter are derived from mannans and mannoproteins. Studies by Bergbrant *et al.* show increased NK cells and impaired T-cell function in addition to increased total serum IgA and IgG among SD patients. However, *Malassezia*-specific antibody titer was not increased, suggesting that the hypergammaglobulinemia may be produced in response to yeast toxins and lipases.

In those suffering from dandruff, the corneocytes of skin are seen loosely associated and the desmosome numbers are either reduced or absent. The lipids that are normally secreted are also decreased, which in turn affect the epidermal water barrier. Histamine-associated itching is also shown to be increased, contributing to trauma and loss of defense mechanism of the skin. This facilitates *Malassezia* to penetrate into the skin. They produce lipases to breakdown sebum into arachidonic acid and oleic acid, which are both irritants and have desquamative effects on keratinocytes. This starts off the inflammation and it becomes a vicious cycle.

At a given point of time, *Malasseziae* have the ability to exist as pathogens causing SD, and as normal flora elsewhere. They are able to exert an immunomodulatory response. They trigger the classical and the alternate pathways of the complement cascade. C3 has been found from lesional skin and this is postulated to be one of the reasons for the inflammatory reactions. Though ideally the yeast should be phagocytized and eliminated by our immune system, they downregulate and are able to suppress the secretion of cytokines and interleukins.

*Malassezia* modifies and escapes the local immune response, and host susceptibility by producing secondary metabolites, which helps in maintaining seborrheic dermatitis.\[[@ref29]\] Environmental factors, such as stress, UV radiation, climatic changes, hormonal changes and trauma probably also help in maintaining seborrheic dermatitis.\[[@ref29]\]

**Cradle cap**: Infantile or neonatal SD is also known as pityriasis capitis, *crusta lactea*, *milk crust*, nonitching lesion on the scalp of new born (Cradle cap directory, WebMD. Retrieved 26 August 2012).

Infantile seborrheic dermatitis is seen commonly between the 2^nd^ week up to 6 months. It may be eczematous or psoriasiform and it can also rarely involve the face, trunk, and sternum. The lesions may be single or in multiple sites, and may coalesce, especially on the face and flexures.\[[@ref16]\]

Neonatal cephalic pustulosis (neonatal acne)

*Malassezia* colonization starts on day 1 from the mother, health care workers and increases during the first weeks of life. Several factors like environmental and maternal hormonal levels influence colonization. A high prevalence of *M. sympodialis* in neonates is noted from birth. It is known to cause neonatal acne.\[[@ref30]\]

Malassezi folliculitis

*SYNONYM*: *Pityrosporum* folliculitis (PF). It is a highly pruritic, follicular papulopustular eruption/rash seen commonly in the upper trunk. It is seen in the young age group and rarely seen post middle age.

Though it was first described in 1969 by Weary *et al.*, it was found to be a separate entity based on histologic ultrastructure by Potter *et al.*, in 1973. This is a chronic infection, where patients typically present with erythematous, papules and pustule in the chest or back, in a follicular pattern. The hallmark symptom is pruritis. Rarely its seen on the face, neck shoulders and arms.\[[@ref6][@ref16][@ref31][@ref32]\]

Risk factors for Malassezia folliculitis:\[[@ref33][@ref34][@ref35][@ref36][@ref37][@ref38]\]

ImmunosuppressionDiabetes mellitusBroad-spectrum antibioticsSteroidsPuberty,PregnancyCosmetics, lotions, sunscreens, emollients, olive oil which cause occlusion of the skin.

Diagnosis:The diagnosis of Pityrosporum folliculitis is based on clinical suspicion and response to antifungal therapy.

Histopathological findings: On microscopy, a scraping of the pustule will show budding yeast forms and spores, and not the hyphae as seen in tinea versicolor. A biopsy is generally not required to diagnose Pityrosporum folliculitis however histology shows a dilated ostium of the hair follicles with lot of cellular material and keratin plugs. An inflammatory response showing lymphocytes, histiocytes, and neutrophils can be seen. The infundibulum is surrounded by monocytes and mucin deposits. *Malassezia* yeast can be identified in the central and deep follicle; however, they are more in number in the ostium and pilary canal. Special fungal stains like Periodic acid--Schiff (PAS) and Grocott-Gomori methenamine-silver staining (GMS) can be used to highlight the unipolar budding yeast cells though mycelial forms are not made out with these stains.\[[@ref39][@ref40][@ref41]\]

Treatment

In treating *Pityrosporum* folliculitis, it is advisable to use oral antifungal agents, as topical agents do not penetrate well into the hair follicles. Since there is high incidence of recurrence, there is a need for maintenance therapy.

### Atopic eczema/dermatitis syndrome {#sec3-3}

Atopic dermatitis (AD) is a chronic, familial inflammatory skin disease associated with asthma. The pathogenesis is not clearly understood. Patients present with itching, which could be the body\'s reaction to irritants or microorganisms, brought about by loss of surface barrier mechanisms and dry skin \[[Figure 1](#F1){ref-type="fig"}\].\[[@ref3][@ref42][@ref43]\]

![Malassezia in atopic/eczema dermatitis syndrome](IJD-60-332-g001){#F1}

*Malassezia* as an agent in AD became popular after studies found ketoconazole as a successful therapeutic agent.\[[@ref44]\]

Their multilamellar cell wall and mannan are antigenic. There is high titer of *Malassezia*-specific IgE, among patients and they also show positive skin prick tests.

*Malassezia* might act a continuous allergic stimulus. The cellular and humoral immune response together lead to increased sensitization. The cellular response is mainly of the Th2 type with an increased IL 4 and IL 5 production as compared to healthy controls.

There is continued production of IgE due to the association of the cytokines with IgE-mediated reaction resulting in the release of histamines due to allergen-specific IgE on mast cells.

The symptoms of itching due to this histamine release leads to further sensitization of *Malassezia*.

Antifungal agents lead to a decrease in the population of yeast on the skin thereby reducing the antigen load which interferes with the inflammatory cycle.

*M. sympodialis*, *M. furfur* and lately, *M. globosa* have been found to have this type of IgE.

Isolation and speciation

Several studies have been done to look for the most common species but among *M. globosa*, *M. restricta*, *M. sympodialis* and *M. furfur* all have been commonly isolated.

*M. globosa* allergen corresponds to heat shock protein 70 (HSP70).

*M. dermatis* was a new species described by Sugita *et al.*, 2002, isolated from patients with AD in Japan. However, they suggest that more studies should be undertaken in other countries also to see if this species is the causative agent in AD as seen in Japan.

The pathogenesis is not well understood. Malassezia are known to produce IgE-binding allergens, and this plays an important role in pathogenesis. More studies are needed to understand the role of *Malassezia* and its mechanisms of disease, chronicity and exacerbations.\[[@ref3][@ref16][@ref42][@ref43][@ref44][@ref45][@ref46][@ref47][@ref48][@ref49][@ref50][@ref51][@ref52][@ref53]\]

### Psoriasis {#sec3-4}

Chronic plaque psoriasis or psoriasis vulgaris has been documented to be caused and aggrevated by *Malassezia*. The association was first proposed by Rivolta *et al.* as early as 1873. Narang *et al.*, 2007,\[[@ref54]\] also observed them in lesions and also noticed that they subsided after fluconazole treatment.

Among psoriatic patients, especially those who have lesions involving the scalp, eyebrows, ears and seborrhoeic areas of the trunk *Malassezia* has a strong association. A case report Elewski *et al.* in 1990\[[@ref55]\] reported a case of guttate psoriasis in areas of *Malassezia* folliculitis.

Some differences have been noted in the epidemiological data and distribution of *Malassezia*, like,

Low *Malassezia* colony count in comparison to normal skin and other diseases it causes andKnown pathogenic strains that have not been isolated in psoriasis.

Pathogenesis

The pathogenesis is proven to be by the T-cell activation and cytokine release but what triggers this is considered to be multifactorial, like stress, infections, trauma, drug association etc., and is not well understood.

Autoantigens: Keratin 13 has homology to K17 the identified candidate autoantigen, which is not seen in adults normally, but brought on during trauma.

This explains Koebners phenomenon, where new lesion crop up at sites of trauma. Neutrophils are seen in the skin infiltrate of psoriatic skin which in turn increased chemotactic response.

This is not seen in other etiology like Staphylococci.

Superantigens are those that bind to Vß region and bring about a huge tsunami of cytokines. Superantigens produced by infections like Staphylococci, Streptococci elicit such responses that aggravate AD of the guttate type or the chronic plaque variety.

It can only be said that it contributes to the inflammation associated with the disease, by activating complement production of pro inflammatory cytokines and neutrophil recruitment, but it has not been proven to be indispensible in the pathogenesis of the disease.

The reason for the diminished *Malassezia* population on psoriatic skin could be due to the fact that the keratinocytes produce antimicrobial peptides. These peptides deplete the normal bacterial microbiota in the affected region and allow selective overgrowth of *Malassezia*. This overgrowth in itself stresses the predisposed keratinocytes more and increase in the level of LL37 (human cationic antimicrobial protein) is seen. This might trigger development of psoriatic lesions. However, the colony count is always less compared to healthy controls. The reason for this is not very clear but could be due to the inhibitory effect of LL37 seen in psoriatic patients.\[[@ref3][@ref16][@ref56]\]

Indirubin, an Indole produced by *Malassezia*, has successfully been used in treatment, further emphasizing *Malassezia\'s* association with this disease.\[[@ref3][@ref16][@ref56][@ref57]\]

### Onychomycoses {#sec3-5}

*Malassezia* lack enzymes for keratolytic activity. They are lipophilic and since nails are not good sources of lipid and since there are no lipids under the nail plate, they do not colonize nails. It is not clear whether *Malassezia* is a pathogenic agent but therapeutic success has been achieved with antifungals and hence it is not considered as primary pathogen in onychomycosis.\[[@ref2][@ref57]\]

### Illnesses rarely caused by *Malassezia* {#sec3-6}

See [Table 1](#T1){ref-type="table"}.

###### 

Illnesses rarely caused by Malassezia

![](IJD-60-332-g002)

### Malassezia in systemic disease {#sec3-7}

*Malassezia* was reported as an agent that complicated the continuous ambulatory peritoneal dialysis (CAPD) of a patient with chronic renal failure. Several cases have been reported since then, implicating *Malassezia* in culture-negative peritonitis.

Hassal *et al.* reported pulmonary embolus and a *Malassezia* pulmonary infection in a patient who was on urokinase therapy.

### Malassezia catheter-related blood stream infections {#sec3-8}

Catheter-associated *Malassezia* sepsis has been reported in low-birth-weight infants, and patients in intensive care units who have been on TPN and those who have other pre disposing conditions. In literature, only two species namely *M. furfur* and *M. pachydermatis* are proven agents in systemic disease.\[[@ref66][@ref67][@ref68][@ref69][@ref70][@ref71][@ref72][@ref73][@ref74]\]

### M. Pachydermatis in human infections {#sec3-9}

This species was isolated by Weidman in 1925 from a captive Indian rhinoceros. He named it *Pityrosporum pachydermatis*.\[[@ref75]\] Dodge *et al* in 1935 transferred it to the genus *Malassezia*. This species is also seen as normal flora in pet animals like dogs, cats, and in wild animals too. Skin colonization is common among pet owners

The first case of *M. pachydermatis* CAPD peritonitis was described in 1983 in an insulin-dependent diabetic on continuous ambulatory peritoneal dialysis.

*M. pachydermatis* was the cause of fungemia in a neonatal ICU, affecting eight premature, low-birth-weight neonates who received TPN with lipid supplementation. *M. pachydermatis* was isolated from blood (6/8 neonates), tracheal aspirate (2/8), eye (1/8) and nose (1/8) secretions, and urine (1/8).\[[@ref76]\]

*M. pachydermatis* can cause outbreaks because it can persist on incubator surfaces for up to 3 months despite standard disinfection. Thus, meticulous personal hygiene of medical and health care staff handling neonates as well as modifications of the cleansing procedures were implemented.\[[@ref73]\] Colonization of the pet owners has been proven by high rates of amplified DNA compared to those who had no pets.

Thus, in the risk group, *M. pachydermatis* is a potential pathogen.\[[@ref16]\]

*Malassezia pachydermatis* has been isolated from the facial granuloma of a healthy woman and her dog\'s skin scrapings and cerumen. The skin lesions healed after oral fluconazole and cryotherapy.

Conclusion {#sec1-5}
==========

Genus *Malassezia* is known to man for more than 150 yrs as a commensal and pathogen. Though not usually life threatening, causing only chronic recurring superficial mycoses in majorities, it is under the scanner for the spectrum of diseases it can cause, including the systemic infections. It is a potential pathogen among predisposed and ICU patients. Another concern is the introduction of seven new species in post taxonomic revision. More studies need to be done to know about their behavior in clinical settings. Minimal inhibitory concentration of the antifungal drugs used against the newly identified species also needs to be studied.

**What is new?**

The newer associations between agent and diseases like atopic dermatitis, psoriasis etcDocumentations of high MICs makes it mandatory for us to know the spectrum of diseases which *Malassezia* could cause including the rare ones.
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